A Pharmacokinetics, Pharmacodynamics, and Safety Study of an Oral Contraceptive Containing Norethindrone and Ethinyl Estradiol When Co-administered With GSK1322322 in Healthy Adult Women

Condition:   Infections, BacterialInterventions:   Drug: GSK1322322;   Drug: EE/NE;   Drug: GSK1322322 Placebo;   Drug: EE/NE PlaceboSponsor:   GlaxoSmithKlineWithdrawn - verified January 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials